Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: The role of cyclic GMP and tyrosine phosphatase inhibition

Journal of Immunology

Volumn 161, Issue 9, 1998, Pages 4852-4858

  Callsen, Dagmar ^a   Pfeilschifter, Josef ^b   Brüne, Bernhard ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 8 BROMO CYCLIC GMP; CYCLIC GMP; CYTOKINE; DIPHENYLIODONIUM SALT; ENZYME INHIBITOR; GAMMA INTERFERON; INTERLEUKIN 1BETA; LINSIDOMINE; MITOGEN ACTIVATED PROTEIN KINASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROTEIN TYROSINE PHOSPHATASE; S NITROSOGLUTATHIONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GLOMERULONEPHRITIS; IMMUNOPRECIPITATION; INFLAMMATION; KIDNEY DISEASE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ACETYLCYSTEINE; ANIMALS; BIPHENYL COMPOUNDS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; CYCLIC GMP; ENZYME ACTIVATION; FREE RADICAL SCAVENGERS; GLOMERULAR MESANGIUM; GLUTATHIONE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MOLSIDOMINE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; ONIUM COMPOUNDS; OXADIAZOLES; OXAZINES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-TYROSINE-PHOSPHATASE; RATS; S-NITROSOGLUTATHIONE; SECOND MESSENGER SYSTEMS;

EID: 0032211074     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Michael, A. F., W. F. Keane, L. Raij, R. L. Vernier, and S. M. Mauer. 1980. The glomerular mesangium. Kidney Int. 17:141.
2. Pfeilschifter, J. 1995. Does nitric oxide, an inflammatory mediator of glomerular mesangial cells, have a role in diabetic nephropathy? Kidney Int. Suppl. 51:550.
3. Raij, L., and C. Baylis. 1995. Glomerular actions of nitric oxide [editorial]. Kidney Int. 48:20.
4. Bokemeyer, D., K. E. Guglielmi, A. McGinty, A. Sorokin, E. A. Lianos, and M. J. Dunn. 1997. Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats. J. Clin. Invest. 100:582.
5. Cattell, V., E. Lianos, P. Largen, and T. Cook. 1993. Glomerular NO synthase activity in mesangial cell immune injury. Exp. Nephrol. 1:36.
6. Pfeilschifter, J., P. Rob, A. Mülsch, J. Fandrey, K. Vosbeck, and R. Busse. 1992. Interleukin 1 β and tumour necrosis factor a induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur. J. Biochem. 203:251.
7. Narita, I., W. A. Border, M. Ketteler, and N. A. Noble. 1995. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab. Invest. 72:17.
8. Pipili-Synetos, E., A. Papageorgiou, E. Sakkoula, G. Sotiropuolou, T. Fotsis, G. Karakiulakis, and M. E. Maragoudakis. 1995. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br. J. Pharmacol. 116:1829.
9. Kuzin, B., I. Roberts, N. Peunova, and G. Enikolopov. 1996. Nitric oxide regulates cell proliferation during Drosophila development. Cell 87:639.
10. Parenti, A., L. Morbidelli, X. L. Cui, J. G. Douglas, J. D. Hood, H. J. Granger, F. Ledda, and M. Ziche. 1998. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. J. Biol. Chem. 273:4220.
11. Clark, J. E., C. J. Green, and R. Motterlini. 1997. Involvement of the heme oxygenase-carbon monoxide pathway in keratinocyte proliferation. Biochem. Biophys. Res. Commun. 241:215.
12. Du, M., M. M. Islam, L. Lin, Y. Ohmura, Y. Moriyama, and S. Fujimura. 1997. Promotion of proliferation of murine BALB/C3T3 fibroblasts mediated by nitric oxide at lower concentrations. Biochem. Mol. Biol. Int. 41:625.
13. Pages, G., P. Lenormand, G. L'Allemain, J. C. Chambard, S. Meloche, and J. Pouyssegur. 1993. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90:8319.
14. Davis, R. J. 1993. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:14553.
15. Guan, K. L. 1994. The mitogen activated protein kinase signal transduction pathway: from the cell surface to the nucleus. Cell. Signal. 6:581.
16. Anderson, N. G., J. L. Maller, N. K. Tonks, and T. W. Sturgill. 1990. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature 343:651.
17. Zheng, C. F., and K. L. Guan. 1994. Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues. EMBO J. 13:1123.
18. Seger, R., and E. G. Krebs. 1995. The MAPK signaling cascade. FASEB J. 9:726.
19. Waskiewicz, A. J., and J. A. Cooper. 1995. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell Biol. 7:798.
20. Hunter, T. 1995. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80:225.
21. Keyse, S. M. 1995. An emerging family of dual specificity MAP kinase phosphatases. Biochim. Biophys. Acta 1265:152.
22. Wu, J., L. F. Lau, and T. W. Sturgill. 1994. Rapid deactivation of MAP kinase in PC12 cells occurs independently of induction of phosphatase MKP-1. FEBS Lett. 353:9.
23. Sun, H., C. H. Charles, L. F. Lau, and N. K. Tonks. 1993. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75:487.
24. Alessi, D. R., N. Gomez, G. Moorhead, T. Lewis, S. M. Keyse, and P. Cohen. 1995. Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr. Biol. 5:283.
25. Fauman, E. B., and M. A. Saper. 1996. Structure and function of the protein tyrosine phosphatases. Trends Biochem. Sci. 21:413.
26. Guan, K. L., and J. E. Dixon. 1991. Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. J. Biol. Chem. 266: 17026.
27. Stone, R. L., and J. E. Dixon. 1994. Protein-tyrosine phosphatases. J. Biol. Chem. 269:31323.
28. Stamler, J. S. 1994. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931.
29. Nathan, C., and Q. W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915.
30. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051.
31. Feelisch, M., and J. S. Stamler. 1996. Donors of nitrogen oxides. In Methods in Nitric Oxide Research. M. A. Feelisch and J. S. Stamler, eds. John Wiley & Sons, New York, p. 71.
32. Pfeilschifter, J., and K. Vosbeck. 1991. Transforming growth factor β 2 inhibits interleukin 1 β- and tumour necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells. Biochem. Biophvs. Res. Commun. 175:372.
33. Hart, T. W. 1985. Some observations concerning the S-nitroso and S-phenylsulphonyl derivates of L-cysteine and glutathione. Tetrahedron Lett. 26:2013.
34. Messmer, U. K., E. G. Lapetina, and B. Brüne. 1995. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol. Pharmacol. 47:757.
35. Huwiler, A., S. Stabel, D. Fabbro, and J. Pfeilschifter. 1995. Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonists. Biochem. J. 305:777.
36. Wu, X. B., B. Brüne, F. von Appen, and V. Ullrich. 1993. Efflux of cyclic GMP from activated human platelets. Mol. Pharmacol. 43:564.
37. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489.
38. Cross, A. R., and O. T. Jones. 1986. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils: specific labelling of a component polypeptide of the oxidase. Biochem. J. 273:111.
39. Mülsch, A., J. Bauersachs, A. Schafer, J. P. Stasch, R. Kast, and R. Busse. 1997. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br. J. Pharmacol. 120:681.
40. Ottlinger, M. E., L. A. Pukac, and M. J. Kamovsky. 1993. Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. J. Biol. Chem. 268:19173.
41. Dinarello, C. A. 1991. Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627.
42. Coyne, D. W., and A. R. Morrison. 1990. Effect of the tyrosine kinase inhibitor, genistein, on interleukin-1 stimulated PGE2 production in mesangial cells. Biochem. Biophys. Res. Commun. 173:718.
43. Pfeilschifter, J., and H. Schwarzenbach. 1990. Interleukin 1 and tumor necrosis factor stimulate cGMP formation in rat renal mesangial cells. FEBS Lett. 273: 185.
44. Huwiler, A., and J. Pfeilschifter. 1994. Interleukin-1 stimulates de novo synthesis of mitogen-activated protein kinase in glomerular mesangial cells. FEBS Lett. 350:135.
45. Wilmer, W. A., L. C. Tan, J. A. Dickerson, M. Danne, and B. H. Rovin. 1997. Interleukin-1β induction of mitogen-activated protein kinases in human mesangial cells: role of oxidation. J. Biol. Chem. 272:10877.
46. Brondello, J. M., A. Brunet, J. Pouyssegur, and F. R. McKenzie. 1997. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44 MAPK cascade. J. Biol. Chem. 272:1368.
47. Lander, H. M., A. T. Jacovina, R. J. Davis, and J. M. Tauras. 1996. Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J. Biol. Chem. 271:19705.
48. Lander, H. M., D. P. Hajjar, B. L. Hempstead, U. A. Mirza, B. T. Chait, S. Campbell, and L. A. Quilliam. 1997. A molecular redox switch on p21(ras): structural basis for the nitric oxide-p21(ras) interaction. J. Biol. Chem. 272:4323.
49. Vossler, M. R., H. Yao, R. D. York, M. G. Pan, C. S. Rim, and P. J. Stork. 1997. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89:73.
50. Sugimoto, T., M. Haneda, M. Togawa, M. Isono, T. Shikano, S. Araki, T. Nakagawa, A. Kashiwagi, K. L. Guan, and R. Kikkawa. 1996. Atrial natriuretic peptide induces the expression of MKP-1, a mitogen-activated protein kinase phosphatase, in glomerular mesangial cells. J. Biol. Chem. 271:544.
51. Barford, D. 1995. Protein phosphatases. Curr. Opin. Struct. Biol. 5:728.
52. Cavigelli, M., W. W. Li, A. Lin, B. Su, K. Yoshioka, and M. Karin. 1996. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J. 15:6269.
53. Caselli, A., P. Chiarugi, G. Camici, G. Manao, and G. Ramponi. 1995. In vivo inactivation of phosphotyrosine protein phosphatases by nitric oxide. FEBS Lett. 374:249.
54. Caselli, A., G. Camici, G. Manao, G. Moneti, L. Pazzagli, G. Cappugi, and G. Ramponi. 1994. Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase. J. Biol. Chem. 269:24878.
55. Peranovich, T. M., A. M. da Silva, D. M. Fries, A. Stern, and H. P. Moneiro. 1995. Nitric oxide stimulates tyrosine phosphorylation in murine fibroblasts in the absence and presence of epidermal growth factor. Biochem. J. 305:613.